MedPath

Inhibition of virus induced Aggravation of childhood asthma by Salmeterol/Fluticasone Propionate Combination(SFC)

Not Applicable
Conditions
Asthma
Registration Number
JPRN-UMIN000023224
Lead Sponsor
Tsukuba Medical Center Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

SFC or Fluticasone is used as a controller Patients has respiratory diseases except asthma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In patients with a common cold, asthma control was significantly more effective for those treated with SFC compared to treatment with Fluticasone
Secondary Outcome Measures
NameTimeMethod
In 12th week SFC group will show higher Best ACT P score and QOL score than Fluticasone group. SFC group will less freqently to use beta stimulator and less frequently to visit ER department.
© Copyright 2025. All Rights Reserved by MedPath